nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Urinary hesitation—Phenylpropanolamine—obesity	0.0304	0.055	CcSEcCtD
Methylscopolamine bromide—Sweating decreased—Topiramate—obesity	0.0169	0.0306	CcSEcCtD
Methylscopolamine bromide—Hypohidrosis—Topiramate—obesity	0.0169	0.0306	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Diethylpropion—obesity	0.013	0.0236	CcSEcCtD
Methylscopolamine bromide—Cyclandelate—CES1—obesity	0.0121	1	CrCbGaD
Methylscopolamine bromide—Erectile dysfunction—Methamphetamine—obesity	0.00959	0.0174	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Phenylpropanolamine—obesity	0.00697	0.0126	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Phentermine—obesity	0.00689	0.0125	CcSEcCtD
Methylscopolamine bromide—Palpitations—Methamphetamine—obesity	0.00641	0.0116	CcSEcCtD
Methylscopolamine bromide—Palpitations—Benzphetamine—obesity	0.00618	0.0112	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Phendimetrazine—obesity	0.00601	0.0109	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Diethylpropion—obesity	0.00599	0.0109	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Diethylpropion—obesity	0.0058	0.0105	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Methamphetamine—obesity	0.00578	0.0105	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Bupropion—obesity	0.00576	0.0104	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Cimetidine—obesity	0.0057	0.0103	CcSEcCtD
Methylscopolamine bromide—Palpitations—Phendimetrazine—obesity	0.00563	0.0102	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Benzphetamine—obesity	0.00557	0.0101	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Cimetidine—obesity	0.00552	0.01	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methamphetamine—obesity	0.00536	0.00971	CcSEcCtD
Methylscopolamine bromide—Tension—Phenylpropanolamine—obesity	0.00534	0.00969	CcSEcCtD
Methylscopolamine bromide—Nervousness—Phenylpropanolamine—obesity	0.00529	0.00959	CcSEcCtD
Methylscopolamine bromide—Insomnia—Benzphetamine—obesity	0.00516	0.00936	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Phenylpropanolamine—obesity	0.00513	0.0093	CcSEcCtD
Methylscopolamine bromide—Tension—Phentermine—obesity	0.00511	0.00927	CcSEcCtD
Methylscopolamine bromide—Accommodation disorder—Topiramate—obesity	0.0051	0.00924	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Phendimetrazine—obesity	0.00508	0.0092	CcSEcCtD
Methylscopolamine bromide—Constipation—Methamphetamine—obesity	0.00506	0.00918	CcSEcCtD
Methylscopolamine bromide—Nervousness—Phentermine—obesity	0.00506	0.00917	CcSEcCtD
Methylscopolamine bromide—Insomnia—Phendimetrazine—obesity	0.00471	0.00853	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methamphetamine—obesity	0.0047	0.00852	CcSEcCtD
Methylscopolamine bromide—Palpitations—Phentermine—obesity	0.00461	0.00835	CcSEcCtD
Methylscopolamine bromide—Urticaria—Benzphetamine—obesity	0.00454	0.00822	CcSEcCtD
Methylscopolamine bromide—Confusional state—Phenylpropanolamine—obesity	0.00448	0.00812	CcSEcCtD
Methylscopolamine bromide—Constipation—Phendimetrazine—obesity	0.00445	0.00807	CcSEcCtD
Methylscopolamine bromide—Tension—Diethylpropion—obesity	0.00445	0.00806	CcSEcCtD
Methylscopolamine bromide—Nervousness—Diethylpropion—obesity	0.0044	0.00798	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methamphetamine—obesity	0.00436	0.00791	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Phentermine—obesity	0.00434	0.00787	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Phenylpropanolamine—obesity	0.00434	0.00786	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Diethylpropion—obesity	0.00427	0.00774	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Benzphetamine—obesity	0.00421	0.00762	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Phentermine—obesity	0.00415	0.00752	CcSEcCtD
Methylscopolamine bromide—Insomnia—Phenylpropanolamine—obesity	0.00402	0.00729	CcSEcCtD
Methylscopolamine bromide—Palpitations—Diethylpropion—obesity	0.00401	0.00726	CcSEcCtD
Methylscopolamine bromide—Somnolence—Phenylpropanolamine—obesity	0.00395	0.00716	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methamphetamine—obesity	0.00392	0.0071	CcSEcCtD
Methylscopolamine bromide—Insomnia—Phentermine—obesity	0.00385	0.00697	CcSEcCtD
Methylscopolamine bromide—Constipation—Phenylpropanolamine—obesity	0.0038	0.00689	CcSEcCtD
Methylscopolamine bromide—Dizziness—Benzphetamine—obesity	0.00378	0.00684	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Diethylpropion—obesity	0.00378	0.00684	CcSEcCtD
Methylscopolamine bromide—Headache—Methamphetamine—obesity	0.00371	0.00672	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Topiramate—obesity	0.00367	0.00666	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Phenylpropanolamine—obesity	0.00366	0.00664	CcSEcCtD
Methylscopolamine bromide—Constipation—Phentermine—obesity	0.00364	0.00659	CcSEcCtD
Methylscopolamine bromide—Ageusia—Topiramate—obesity	0.00362	0.00655	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Diethylpropion—obesity	0.00361	0.00655	CcSEcCtD
Methylscopolamine bromide—Headache—Benzphetamine—obesity	0.00358	0.00648	CcSEcCtD
Methylscopolamine bromide—Confusional state—Cimetidine—obesity	0.00355	0.00643	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cimetidine—obesity	0.00352	0.00638	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Orlistat—obesity	0.00344	0.00624	CcSEcCtD
Methylscopolamine bromide—Dizziness—Phendimetrazine—obesity	0.00344	0.00624	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Cimetidine—obesity	0.00344	0.00623	CcSEcCtD
Methylscopolamine bromide—Nausea—Benzphetamine—obesity	0.00339	0.00615	CcSEcCtD
Methylscopolamine bromide—Urticaria—Phentermine—obesity	0.00338	0.00612	CcSEcCtD
Methylscopolamine bromide—Insomnia—Diethylpropion—obesity	0.00335	0.00607	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Sibutramine—obesity	0.00333	0.00604	CcSEcCtD
Methylscopolamine bromide—Somnolence—Diethylpropion—obesity	0.00329	0.00596	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Phenylpropanolamine—obesity	0.00327	0.00594	CcSEcCtD
Methylscopolamine bromide—Headache—Phendimetrazine—obesity	0.00326	0.00591	CcSEcCtD
Methylscopolamine bromide—Constipation—Diethylpropion—obesity	0.00316	0.00574	CcSEcCtD
Methylscopolamine bromide—Somnolence—Cimetidine—obesity	0.00313	0.00567	CcSEcCtD
Methylscopolamine bromide—Nausea—Phendimetrazine—obesity	0.00309	0.0056	CcSEcCtD
Methylscopolamine bromide—Asthenia—Phentermine—obesity	0.00305	0.00553	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Diethylpropion—obesity	0.00305	0.00553	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Sibutramine—obesity	0.00305	0.00552	CcSEcCtD
Methylscopolamine bromide—Constipation—Cimetidine—obesity	0.00301	0.00546	CcSEcCtD
Methylscopolamine bromide—Urticaria—Diethylpropion—obesity	0.00294	0.00533	CcSEcCtD
Methylscopolamine bromide—Dizziness—Phenylpropanolamine—obesity	0.00294	0.00533	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Bupropion—obesity	0.0029	0.00526	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cimetidine—obesity	0.0029	0.00526	CcSEcCtD
Methylscopolamine bromide—Vomiting—Phenylpropanolamine—obesity	0.00283	0.00512	CcSEcCtD
Methylscopolamine bromide—Dizziness—Phentermine—obesity	0.00281	0.0051	CcSEcCtD
Methylscopolamine bromide—Vomiting—Phentermine—obesity	0.0027	0.0049	CcSEcCtD
Methylscopolamine bromide—Headache—Phentermine—obesity	0.00266	0.00483	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Bupropion—obesity	0.00266	0.00481	CcSEcCtD
Methylscopolamine bromide—Nausea—Phenylpropanolamine—obesity	0.00264	0.00479	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cimetidine—obesity	0.00259	0.0047	CcSEcCtD
Methylscopolamine bromide—Nausea—Phentermine—obesity	0.00253	0.00458	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cimetidine—obesity	0.00253	0.00458	CcSEcCtD
Methylscopolamine bromide—Dizziness—Diethylpropion—obesity	0.00245	0.00444	CcSEcCtD
Methylscopolamine bromide—Vomiting—Diethylpropion—obesity	0.00235	0.00426	CcSEcCtD
Methylscopolamine bromide—Dizziness—Cimetidine—obesity	0.00233	0.00422	CcSEcCtD
Methylscopolamine bromide—Headache—Diethylpropion—obesity	0.00232	0.0042	CcSEcCtD
Methylscopolamine bromide—Tension—Sibutramine—obesity	0.00226	0.0041	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Orlistat—obesity	0.00224	0.00407	CcSEcCtD
Methylscopolamine bromide—Nervousness—Sibutramine—obesity	0.00224	0.00406	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cimetidine—obesity	0.00224	0.00406	CcSEcCtD
Methylscopolamine bromide—Headache—Cimetidine—obesity	0.00221	0.004	CcSEcCtD
Methylscopolamine bromide—Nausea—Diethylpropion—obesity	0.0022	0.00398	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Sibutramine—obesity	0.00217	0.00394	CcSEcCtD
Methylscopolamine bromide—Palpitations—Orlistat—obesity	0.0021	0.00381	CcSEcCtD
Methylscopolamine bromide—Nausea—Cimetidine—obesity	0.00209	0.00379	CcSEcCtD
Methylscopolamine bromide—Palpitations—Sibutramine—obesity	0.00204	0.00369	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Orlistat—obesity	0.00198	0.00359	CcSEcCtD
Methylscopolamine bromide—Tension—Bupropion—obesity	0.00197	0.00357	CcSEcCtD
Methylscopolamine bromide—Nervousness—Bupropion—obesity	0.00195	0.00354	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Orlistat—obesity	0.00194	0.00352	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Sibutramine—obesity	0.00192	0.00348	CcSEcCtD
Methylscopolamine bromide—Confusional state—Sibutramine—obesity	0.0019	0.00344	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Bupropion—obesity	0.00189	0.00343	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Sibutramine—obesity	0.00188	0.00341	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Topiramate—obesity	0.00185	0.00335	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Sibutramine—obesity	0.00184	0.00333	CcSEcCtD
Methylscopolamine bromide—Palpitations—Bupropion—obesity	0.00178	0.00322	CcSEcCtD
Methylscopolamine bromide—Insomnia—Orlistat—obesity	0.00176	0.00319	CcSEcCtD
Methylscopolamine bromide—Insomnia—Sibutramine—obesity	0.0017	0.00308	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Topiramate—obesity	0.00169	0.00307	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Bupropion—obesity	0.00167	0.00303	CcSEcCtD
Methylscopolamine bromide—Somnolence—Sibutramine—obesity	0.00167	0.00303	CcSEcCtD
Methylscopolamine bromide—Confusional state—Bupropion—obesity	0.00165	0.003	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Bupropion—obesity	0.00164	0.00297	CcSEcCtD
Methylscopolamine bromide—Constipation—Sibutramine—obesity	0.00161	0.00292	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Orlistat—obesity	0.0016	0.0029	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Bupropion—obesity	0.0016	0.0029	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Sibutramine—obesity	0.00155	0.00281	CcSEcCtD
Methylscopolamine bromide—Urticaria—Orlistat—obesity	0.00154	0.0028	CcSEcCtD
Methylscopolamine bromide—Urticaria—Sibutramine—obesity	0.00149	0.00271	CcSEcCtD
Methylscopolamine bromide—Insomnia—Bupropion—obesity	0.00148	0.00269	CcSEcCtD
Methylscopolamine bromide—Somnolence—Bupropion—obesity	0.00146	0.00264	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Orlistat—obesity	0.00143	0.0026	CcSEcCtD
Methylscopolamine bromide—Constipation—Bupropion—obesity	0.0014	0.00254	CcSEcCtD
Methylscopolamine bromide—Asthenia—Orlistat—obesity	0.00139	0.00253	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Sibutramine—obesity	0.00139	0.00251	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Bupropion—obesity	0.00135	0.00245	CcSEcCtD
Methylscopolamine bromide—Asthenia—Sibutramine—obesity	0.00135	0.00245	CcSEcCtD
Methylscopolamine bromide—Urticaria—Bupropion—obesity	0.0013	0.00236	CcSEcCtD
Methylscopolamine bromide—Dizziness—Orlistat—obesity	0.00129	0.00233	CcSEcCtD
Methylscopolamine bromide—Tension—Topiramate—obesity	0.00126	0.00228	CcSEcCtD
Methylscopolamine bromide—Dizziness—Sibutramine—obesity	0.00124	0.00225	CcSEcCtD
Methylscopolamine bromide—Nervousness—Topiramate—obesity	0.00124	0.00225	CcSEcCtD
Methylscopolamine bromide—Vomiting—Orlistat—obesity	0.00124	0.00224	CcSEcCtD
Methylscopolamine bromide—Headache—Orlistat—obesity	0.00122	0.00221	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Bupropion—obesity	0.00121	0.00219	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Topiramate—obesity	0.00121	0.00219	CcSEcCtD
Methylscopolamine bromide—Vomiting—Sibutramine—obesity	0.0012	0.00217	CcSEcCtD
Methylscopolamine bromide—Headache—Sibutramine—obesity	0.00118	0.00214	CcSEcCtD
Methylscopolamine bromide—Asthenia—Bupropion—obesity	0.00118	0.00213	CcSEcCtD
Methylscopolamine bromide—Nausea—Orlistat—obesity	0.00115	0.00209	CcSEcCtD
Methylscopolamine bromide—Palpitations—Topiramate—obesity	0.00113	0.00205	CcSEcCtD
Methylscopolamine bromide—Nausea—Sibutramine—obesity	0.00112	0.00203	CcSEcCtD
Methylscopolamine bromide—Dizziness—Bupropion—obesity	0.00108	0.00197	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Topiramate—obesity	0.00107	0.00193	CcSEcCtD
Methylscopolamine bromide—Confusional state—Topiramate—obesity	0.00105	0.00191	CcSEcCtD
Methylscopolamine bromide—Vomiting—Bupropion—obesity	0.00104	0.00189	CcSEcCtD
Methylscopolamine bromide—Headache—Bupropion—obesity	0.00103	0.00186	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Topiramate—obesity	0.00102	0.00185	CcSEcCtD
Methylscopolamine bromide—Nausea—Bupropion—obesity	0.000974	0.00177	CcSEcCtD
Methylscopolamine bromide—Insomnia—Topiramate—obesity	0.000945	0.00171	CcSEcCtD
Methylscopolamine bromide—Somnolence—Topiramate—obesity	0.000929	0.00168	CcSEcCtD
Methylscopolamine bromide—Constipation—Topiramate—obesity	0.000894	0.00162	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Topiramate—obesity	0.000861	0.00156	CcSEcCtD
Methylscopolamine bromide—Urticaria—Topiramate—obesity	0.00083	0.0015	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Topiramate—obesity	0.00077	0.0014	CcSEcCtD
Methylscopolamine bromide—Asthenia—Topiramate—obesity	0.00075	0.00136	CcSEcCtD
Methylscopolamine bromide—Dizziness—Topiramate—obesity	0.000691	0.00125	CcSEcCtD
Methylscopolamine bromide—Vomiting—Topiramate—obesity	0.000664	0.0012	CcSEcCtD
Methylscopolamine bromide—Headache—Topiramate—obesity	0.000655	0.00119	CcSEcCtD
Methylscopolamine bromide—Nausea—Topiramate—obesity	0.000621	0.00112	CcSEcCtD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—obesity	3.7e-05	8.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LPL—obesity	3.7e-05	8.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—obesity	3.7e-05	8.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—obesity	3.7e-05	8.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—obesity	3.69e-05	8.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLG—obesity	3.68e-05	8.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—RHOA—obesity	3.67e-05	8.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STK11—obesity	3.67e-05	8.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLG—obesity	3.67e-05	8.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CAV1—obesity	3.66e-05	8.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—RHOA—obesity	3.66e-05	8.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—obesity	3.66e-05	8.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOA1—obesity	3.66e-05	8.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT2—obesity	3.64e-05	8.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3R1—obesity	3.64e-05	8.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLG—obesity	3.63e-05	8.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT2—obesity	3.63e-05	8.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—RHOA—obesity	3.63e-05	8.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3R1—obesity	3.62e-05	8.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—obesity	3.61e-05	8.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT2—obesity	3.59e-05	8.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FOXO3—obesity	3.59e-05	8.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3R1—obesity	3.59e-05	8.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRB2—obesity	3.58e-05	8.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FOXO3—obesity	3.58e-05	8.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRB2—obesity	3.57e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FOXO3—obesity	3.55e-05	8.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRB2—obesity	3.54e-05	8.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ESR1—obesity	3.53e-05	8.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS1—obesity	3.53e-05	8.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD36—obesity	3.52e-05	8.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS1—obesity	3.52e-05	8.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CD—obesity	3.5e-05	8.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKCB—obesity	3.49e-05	7.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—F2—obesity	3.49e-05	7.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CD—obesity	3.49e-05	7.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS3—obesity	3.48e-05	7.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS1—obesity	3.48e-05	7.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS3—obesity	3.47e-05	7.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CD—obesity	3.45e-05	7.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BAD—obesity	3.45e-05	7.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS3—obesity	3.44e-05	7.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNB3—obesity	3.41e-05	7.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNB3—obesity	3.4e-05	7.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNB3—obesity	3.37e-05	7.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TYK2—obesity	3.36e-05	7.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CB—obesity	3.36e-05	7.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TYK2—obesity	3.35e-05	7.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—obesity	3.35e-05	7.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CB—obesity	3.35e-05	7.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—obesity	3.34e-05	7.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CG—obesity	3.34e-05	7.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—RHOA—obesity	3.34e-05	7.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—obesity	3.33e-05	7.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RHOA—obesity	3.33e-05	7.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNAS—obesity	3.32e-05	7.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TYK2—obesity	3.32e-05	7.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CB—obesity	3.31e-05	7.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNAS—obesity	3.31e-05	7.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—obesity	3.31e-05	7.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3R1—obesity	3.3e-05	7.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IRS1—obesity	3.3e-05	7.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RHOA—obesity	3.29e-05	7.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3R1—obesity	3.29e-05	7.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNAS—obesity	3.28e-05	7.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARA—obesity	3.27e-05	7.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3R1—obesity	3.26e-05	7.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOB—obesity	3.25e-05	7.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOB—obesity	3.24e-05	7.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOB—obesity	3.21e-05	7.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—obesity	3.18e-05	7.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—obesity	3.18e-05	7.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—obesity	3.17e-05	7.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—obesity	3.17e-05	7.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—obesity	3.16e-05	7.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—obesity	3.14e-05	7.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—obesity	3.11e-05	7.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—obesity	3.11e-05	7.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—obesity	3.1e-05	7.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—obesity	3.1e-05	7.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FOXO1—obesity	3.08e-05	7.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RPS6KB1—obesity	3.08e-05	7.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAV1—obesity	3.07e-05	7.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FOXO1—obesity	3.07e-05	7.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RPS6KB1—obesity	3.07e-05	7.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—obesity	3.07e-05	7.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—obesity	3.07e-05	7.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—obesity	3.06e-05	7.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT2—obesity	3.05e-05	7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CB—obesity	3.05e-05	6.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FOXO1—obesity	3.04e-05	6.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RPS6KB1—obesity	3.04e-05	6.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CB—obesity	3.04e-05	6.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CB—obesity	3.01e-05	6.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CD—obesity	2.93e-05	6.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—obesity	2.91e-05	6.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—obesity	2.9e-05	6.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCD—obesity	2.86e-05	6.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCD—obesity	2.85e-05	6.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCD—obesity	2.82e-05	6.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TYK2—obesity	2.82e-05	6.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—obesity	2.8e-05	6.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—obesity	2.8e-05	6.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RHOA—obesity	2.8e-05	6.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—C3—obesity	2.8e-05	6.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—obesity	2.79e-05	6.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C3—obesity	2.79e-05	6.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—obesity	2.77e-05	6.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3R1—obesity	2.77e-05	6.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—obesity	2.76e-05	6.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C3—obesity	2.76e-05	6.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—obesity	2.7e-05	6.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—obesity	2.67e-05	6.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IRS2—obesity	2.66e-05	6.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—obesity	2.66e-05	6.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IRS2—obesity	2.65e-05	6.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—obesity	2.65e-05	6.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—obesity	2.65e-05	6.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—obesity	2.64e-05	6.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IRS2—obesity	2.63e-05	6.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—obesity	2.62e-05	6.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—obesity	2.6e-05	5.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—obesity	2.6e-05	5.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—obesity	2.6e-05	5.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—obesity	2.6e-05	5.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—obesity	2.58e-05	5.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—obesity	2.57e-05	5.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—obesity	2.57e-05	5.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—obesity	2.57e-05	5.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—obesity	2.57e-05	5.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—obesity	2.57e-05	5.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—obesity	2.56e-05	5.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CB—obesity	2.56e-05	5.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—obesity	2.55e-05	5.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—obesity	2.54e-05	5.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—obesity	2.49e-05	5.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—obesity	2.48e-05	5.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CD—obesity	2.46e-05	5.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCB—obesity	2.46e-05	5.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—F2—obesity	2.46e-05	5.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—obesity	2.45e-05	5.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCB—obesity	2.45e-05	5.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—F2—obesity	2.45e-05	5.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—obesity	2.43e-05	5.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BAD—obesity	2.43e-05	5.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCB—obesity	2.42e-05	5.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—F2—obesity	2.42e-05	5.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BAD—obesity	2.42e-05	5.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BAD—obesity	2.39e-05	5.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—obesity	2.37e-05	5.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—obesity	2.35e-05	5.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—obesity	2.34e-05	5.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—obesity	2.34e-05	5.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3R1—obesity	2.33e-05	5.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—obesity	2.33e-05	5.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IRS1—obesity	2.32e-05	5.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—obesity	2.32e-05	5.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IRS1—obesity	2.32e-05	5.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IRS1—obesity	2.29e-05	5.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—obesity	2.24e-05	5.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—obesity	2.23e-05	5.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—obesity	2.22e-05	5.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—obesity	2.22e-05	5.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—obesity	2.22e-05	5.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—obesity	2.21e-05	5.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—obesity	2.2e-05	5.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—obesity	2.19e-05	5.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—obesity	2.18e-05	5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—obesity	2.16e-05	4.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—obesity	2.16e-05	4.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—obesity	2.16e-05	4.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—obesity	2.15e-05	4.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT2—obesity	2.15e-05	4.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CB—obesity	2.15e-05	4.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—obesity	2.14e-05	4.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT2—obesity	2.14e-05	4.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—obesity	2.13e-05	4.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—obesity	2.12e-05	4.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT2—obesity	2.12e-05	4.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CD—obesity	2.07e-05	4.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CD—obesity	2.06e-05	4.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—obesity	2.05e-05	4.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—obesity	2.04e-05	4.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—obesity	2.04e-05	4.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CD—obesity	2.04e-05	4.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—obesity	2.04e-05	4.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	2.02e-05	4.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—obesity	2.02e-05	4.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TYK2—obesity	1.99e-05	4.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TYK2—obesity	1.98e-05	4.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—obesity	1.98e-05	4.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RHOA—obesity	1.97e-05	4.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RHOA—obesity	1.96e-05	4.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TYK2—obesity	1.96e-05	4.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3R1—obesity	1.95e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—obesity	1.95e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RHOA—obesity	1.95e-05	4.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3R1—obesity	1.94e-05	4.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—obesity	1.94e-05	4.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3R1—obesity	1.93e-05	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—obesity	1.93e-05	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—obesity	1.86e-05	4.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—obesity	1.85e-05	4.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—obesity	1.84e-05	4.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.83e-05	4.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—obesity	1.83e-05	4.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CB—obesity	1.8e-05	4.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—obesity	1.8e-05	4.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—obesity	1.79e-05	4.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CB—obesity	1.79e-05	4.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—obesity	1.78e-05	4.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CB—obesity	1.78e-05	4.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—obesity	1.67e-05	3.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—obesity	1.67e-05	3.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—obesity	1.65e-05	3.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—obesity	1.65e-05	3.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—obesity	1.64e-05	3.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—obesity	1.62e-05	3.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—obesity	1.56e-05	3.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—obesity	1.56e-05	3.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—obesity	1.56e-05	3.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—obesity	1.54e-05	3.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—obesity	1.52e-05	3.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—obesity	1.52e-05	3.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—obesity	1.52e-05	3.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—obesity	1.51e-05	3.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—obesity	1.5e-05	3.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—obesity	1.5e-05	3.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—obesity	1.39e-05	3.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—obesity	1.39e-05	3.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—obesity	1.38e-05	3.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—obesity	1.37e-05	3.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—obesity	1.31e-05	3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—obesity	1.29e-05	2.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—obesity	1.29e-05	2.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—obesity	1.29e-05	2.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—obesity	1.29e-05	2.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—obesity	1.28e-05	2.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—obesity	1.27e-05	2.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—obesity	1.27e-05	2.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—obesity	1.1e-05	2.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—obesity	1.09e-05	2.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—obesity	1.08e-05	2.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—obesity	1.07e-05	2.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—obesity	9.72e-06	2.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—obesity	9.69e-06	2.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—obesity	9.59e-06	2.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—obesity	8.97e-06	2.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—obesity	8.94e-06	2.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—obesity	8.85e-06	2.03e-05	CbGpPWpGaD
